000566 Hainan Haiyao
- 4.68
- -0.11-2.30%
Hainan Haiyao News
Would Hainan Haiyao (SZSE:000566) Be Better Off With Less Debt?
Hainan Haiyao Co., Ltd.'s (SZSE:000566) Shares Climb 56% But Its Business Is Yet to Catch Up
Hainan Haiyao to Set Up Medical Device-Making Joint Venture
Hainan Haiyao: Report for the third quarter of 2024
Individual Investors in Hainan Haiyao Co., Ltd. (SZSE:000566) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 13% Last Week
Hainan Haiyao Disposing Subsidiary's Idle Assets for 120 Million Yuan; Shares Rise 10%
Hainan Haiyao Estimates At Least 15 Million Yuan of Asset Losses Due to Makar Typhoon
Hainan Haiyao: Summary of the 2024 Semi-Annual Report
Hainan Haiyao: 2024 Semi-Annual Report
Hainan Haiyao Vice Chair Resigns
Some Shareholders Feeling Restless Over Hainan Haiyao Co., Ltd.'s (SZSE:000566) P/S Ratio
China Shares Rise On Upcoming Economic Data; Hainan Haiyao Soars 10%
Hainan Haiyao Gets Commercialization Rights for Pharmathen's Schizophrenia Drug; Shares Up 10%
Hainan Haiyao: 2024 Interim Performance Forecast
New Zealand Shares Jump on US Rate Cut Optimism; AFT Pharmaceuticals to Launch Topical Medication in China
Express News | AFT Pharmaceuticals - Agreement With Hainan Haiyao to Distribute Crystaderm Cream in China
Hainan Haiyao (SZSE:000566) Is Carrying A Fair Bit Of Debt
Hainan Haiyao (SZSE:000566) Sheds CN¥363m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years
Individual Investors in Hainan Haiyao Co., Ltd. (SZSE:000566) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 11% Last Week
Hainan Haiyao's Antibiotic Passes Generic Evaluation
No Data
